Nebula Research & Development LLC Acadia Pharmaceuticals Inc Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Nebula Research & Development LLC holds 50,037 shares of ACAD stock, worth $854,131. This represents 0.11% of its overall portfolio holdings.
Number of Shares
50,037
Previous 36,196
38.24%
Holding current value
$854,131
Previous $557 Million
64.93%
% of portfolio
0.11%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding ACAD
# of Institutions
315Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$732 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$238 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$206 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$149 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$125 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.76B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...